Company intelligence / Profile preview

SmartHealth Dx

Irvine, California, United Statessmarthealthdx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

SmartHealth Dx has developed and commercialized diagnostic platforms such as SmartVascular Dx, which has been used clinically with over 200,000 patients to detect vascular inflammation with high sensitivity and specificity. The company is also advancing digital pathology through its slide-free imaging technology, aiming to improve speed and accuracy in tissue diagnostics. Their oncology diagnostic solutions are under active development or early commercialization.

Therapeutic areas: OncologyCardiovascular
Modalities: DeviceDiagnostic testImaging system
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on SmartHealth Dx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SmartHealth Dx.

Explore the full profile